No human transmission of Mycobacterium malmoense in a perfect storm setting

European Respiratory Journal

Volumn 40, Issue 6, 2012, Pages 1576-1578

  Hoefsloot, Wouter ^a   Boeree, Martin J ^a   Van Nieuwkoop, Cees ^b,c   Bernards, Alexandra T ^b   Savelkoul, Paul H M ^d   Van Ingen, Jakko ^a   Van Soolingen, Dick ^a,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSPORIN; ETHAMBUTOL; RIFAMPICIN;

ADULT; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GENE; BACTERIAL TRANSMISSION; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEVER; GENE SEQUENCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALAISE; MALE; MOLECULAR DIAGNOSIS; MYCOBACTERIUM MALMOENSE; NIGHT SWEAT; NONHUMAN; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ADULT; COMMUNICABLE DISEASE CONTROL; GENES, BACTERIAL; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTIOUS DISEASE MEDICINE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS; NETHERLANDS; NONTUBERCULOUS MYCOBACTERIA; PNEUMOTHORAX; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 84871200093     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00096312     Document Type: Letter

References (8)

1. Griffith DE, Aksamit T, Brown-Elliot BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
2. Hoefsloot W, van Ingen J, de Lange WC, et al. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 2009; 34: 926-931.
3. Bruijnesteijn van Coppenraet LE, Savelkoul PH, Buffing N, et al. Amplified fragment length polymorphism analysis of human clinical isolates of Mycobacterium haemophilum from different continents. Clin Microbiol Infect 2009; 15: 924-930.
4. Cangelosi GA, Freeman RJ, Lewis KN, et al. Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol 2004; 42: 2685-2693. (Pubitemid 38747523)
5. van Ingen J, Boeree MJ, Kösters K, et al. Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp nov. Int J Syst Evol Microbiol 2009; 59: 2277-2282.
6. Telenti A, Marchesi F, Balz M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-178. (Pubitemid 23028605)
7. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119: 107-159. (Pubitemid 9116316)
8. Lichtenstein MR, Takimura Y, Thompson JR. Photochromogenic mycobacterial pulmonary infection in a group of hospitalized patients in Chicago. II. Demographic studies. Am Rev Respir Dis 1965; 91: 592-595.